Oral aprepitant

DRUG2 trials

Sponsors

Osaka Medical Center for Cancer and Cardiovascular Diseases, The Hospital for Sick Children

Conditions

ChemotherapyLung cancerNauseaVomiting

Phase 2

Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents

TerminatedNCT01249001

The Hospital for Sick ChildrenChemotherapy, Nausea, Vomiting

Start: 2010-10-31End: 2016-09-28Updated: 2017-04-19

Unknown Phase

CINV by MEC in clinical practice and rescue of it by NK1RA

Active, not recruitingJPRN-UMIN000008430

Osaka Medical Center for Cancer and Cardiovascular DiseasesLung cancer

Start: 2012-07-17Target: 80Updated: 2026-06-29